title: [Aseptic purulent meningitis in two patients co-infected by HTLV-1 and Strongyloides stercoralis].
abstract: Occurrence of anguilluliasis always progresses to hyperinfestation or disseminated anguilluliasis with severe clinical manifestations in carriers of HTLV-1. This prognosis is further illustrated by two new cases of non-septic purulent meningitis observed in two male patients from Guadalope. Ages were 61 and 64 years. In both cases examination of cerebrospinal fluid (CSF) demonstrated pleiocytosis with more than 3000 cells (mostly polynuclear neutrophils) per mm3, protein content greater than 3 g/l, and low sugar level. No soluble germs or antigens were found in the CSF. In both patients Strongyloides stercoralis larvae were detected in stools but not in CSF. Meningitis responded to antibiotic treatment but follow-up tests showed the persistence of larvae in stools despite treatment using thiabendazole. While similar cases of meningitis have been reported in carriers of HTLV-1, the underlying mechanism is still unclear. Co-infection with Strongyloides stercoralis appears to be a predisposing factor. This association may warrant preventive anti-parasitic treatment in patients infected by HTLV-1.
authors.affiliation: Département d'Information Médicale et Santé Publique, CHU de Pointe-à-Pitre, Guadeloupe, Antitles françaises.
authors.forename: L
authors.initials: L
authors.lastname: Foucan
authors.forename: I
authors.initials: I
authors.lastname: Genevier
authors.forename: I
authors.initials: I
authors.lastname: Lamaury
authors.forename: M
authors.initials: M
authors.lastname: Strobel
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000969:Antinematodal Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005243:Feces / Q000469:parasitology; D015490:HTLV-I Infections / Q000150:complications*; D006801:Humans; D008297:Male; D008582:Meningitis, Aseptic / Q000134:cerebrospinal fluid / Q000150:complications* / Q000188:drug therapy; D008875:Middle Aged; D017171:Strongyloides stercoralis; D013322:Strongyloidiasis / Q000150:complications* / Q000188:drug therapy / Q000469:parasitology; D013492:Suppuration; D013827:Thiabendazole / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000969:Antinematodal Agents; D013827:Thiabendazole
vernacular_title: Méningite purulente aseptique chez deux patients co-infectés par HTLV-1 et Strongyloïdes stercoralis.